Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-569-5 | CAS number: 108-29-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2020-07-13 to 2020-11-17
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: B.69 Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage; Official Journal of the European Union, No.L 247
- Version / remarks:
- 31 July 2019
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 18 June 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- γ-valerolactone
- EC Number:
- 203-569-5
- EC Name:
- γ-valerolactone
- Cas Number:
- 108-29-2
- Molecular formula:
- C5H8O2
- IUPAC Name:
- 5-methyloxolan-2-one
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch number of test material: Grosss 542
- Expiration date of the batch: 04 June 2022
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature
Test animals / tissue source
- Species:
- human
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability: OECD accepted in vitro model as part of a turnkey test strategy to assess the eye irritation potential of chemicals
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live: The EpiOcularTM model (OCL-200) is a three-dimensional, non-keratinized tissue construct composed of normal human-derived epidermal keratinocytes used to model the human corneal epithelium. The EpiOcular tissues (surface 0.6 cm²) are cultured on cell culture inserts (MILLICELLs, 10 mm ∅) and are available commercially as kits (EpiOcular™ 200) containing 24 tissues on shipping agarose. The cells used to produce EpiOcular tissue are screened for potential biological contaminants. No contaminations have been detected in this tissue batch.
- RhCE tissue used, including batch number: All cells used to produce EpiOcular are purchased or derived from tissue obtained by MatTek Corporation from accredited institutions (keratinocyte strain 4F1188, Lot No 30669)
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 50 μL - Duration of treatment / exposure:
- 30 minutes
- Duration of post- treatment incubation (in vitro):
- After 12 minutes of post-soak immersion, the tissues were incubated at standard culture conditions for 2 hours (post-incubation period)
- Number of animals or in vitro replicates:
- a single test composed of 2 tissue replicates
- Details on study design:
- - Details of the test procedure used: Using a pipette, fifty microliters (50 μL) undiluted liquid test substance were applied covering the whole tissue surface. Control tissues were applied concurrently with 50 μL sterile deionized water (NC) or with 50 μL methyl acetate (PC). After application, the tissues were placed into the incubator until the total exposure time of 30 minutes was completed.
- Doses of test chemical and control substances used: 50 µL of test chemical/positive control/negative control
- Duration and temperature of exposure and post-exposure incubation periods: Exposure at 37°C for 30 minutes, then post-exposure incubation for 2 hours at 37°C
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals: Prior to testing, the test substance was added to 0.9 mL MTT solution. The mixture was incubated in the dark at about 37°C for 3 hours. A negative control (deionized water) was tested concurrently.
- Number of tissue replicates used per test chemical and controls: 2 replicates per test item/positive control/negative control. Freeze-killed control tissues were not tested as no direct reduction of MTT by the test substance occured.
- Wavelength used for quantifying MTT formazan: Measurement using a filter wavelength 570 nm without reference filter using a SunriseTM Absorbance Reader
- Description of the method used to quantify MTT formazan: The OD570 values determined for the various tissues are a measure of their viability. The ratio of the OD570 of tissues treated with the test material and the mean OD570 values of the NC (percent of control) is used for evaluating whether a test material was an irritant.
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model: Please refer to table 1
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria: Please refer to table 2+3
- Reference to historical data of the RhCE tissue construct: Please refer to table 3
- Positive and negative control means and acceptance ranges based on historical data: Please refer to table 2+3
- Acceptable variability between tissue replicates for positive and negative controls: Please refer to table 2
- Acceptable variability between tissue replicates for the test chemical: Please refer to table 2
Results and discussion
In vitro
Results
- Irritation parameter:
- mean percent tissue viability
- Run / experiment:
- Run 1 (mean of 2 replicate tissues)
- Value:
- 2.5
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: No
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Range of historical values if different from the ones specified in the test guideline: No
Any other information on results incl. tables
Table 4: Individual and mean OD570 values, individual and mean viability values and inter-tissue variability
Test substance identification |
| tissue 1 | tissue 2 | mean | Inter-tissue variability [%] |
NC | mean OD570 | 2.300 | 2.383 | 2.342 |
|
| vability [% of NC] | 98.2 | 101.8 | 100.0 | 3.5 |
Test item | mean OD570 | 0.071 | 0.045 | 0.058 |
|
| vability [% of NC] | 3.0 | 1.9 | 2.5 | 1.1 |
PC | mean OD570 | 0.502 | 0.382 | 0.442 |
|
| vability [% of NC] | 21.4 | 16.3 | 18.9 | 5.1 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 (irritating to eyes) based on GHS criteria
- Remarks:
- The RhCE Test according to OECD guideline 492 showed an eye irritating potential of gamma-Valerolacton.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.